No Data
Historically the most 'competitive'? The Tenth Batch of National Procurement Pharmaceutical Catalog Is Officially Announced with one type having up to 31 companies competing.
①This afternoon, the National Pharmaceutical Joint Procurement Office officially announced the tenth batch of nationally purchased pharmaceutical catalog, with a total of 263 specifications and 62 varieties; ②Several industry insiders have stated that the tenth batch of national procurement will be the largest and most competitive national procurement in history.
Chinares Pharma (03320): dong-e-e-jiao achieved a net income of 1.152 billion yuan in the first 9 months, a year-on-year increase of 46.74%.
chinares pharma (03320) released the performance for the nine months ending September 30, 2024, of dong-e-e-jiao, with total operating income...
CHINARES PHARMA: ANNOUNCEMENTUNAUDITED FINANCIAL RESULTS OFDONG-E-E-JIAO FOR THE NINE MONTHS ENDED30 SEPTEMBER 2024
zheshang: Continuous realization of technological innovation upgrade driving the continuous improvement of performance expectations for innovative drugs and industry chain.
The commercialization period of innovative drugs in the industry chain, driven purely by incremental value, is entering the phase of realization. The scarce incremental prosperity of the pharmaceutical sector continues to rise, with increasing international competitiveness, and there is still room for upward valuation.
Hong Kong healthcare stocks receive attention from investors again, with Trifolium Biotech surging nearly 15%.
①What is the impact of medical insurance negotiations on pharmaceutical stocks? ②What are the reasons for the rise of Tri Clover Biopharmaceutical and Yimington Corporation?
KPC Pharmaceuticals's Nine-Month Profit Rises Slightly
No Data
No Data
